medigraphic.com
ISSN 1527-3172 (Digital)

2012, Número 1

<< Anterior Siguiente >>

MEDICC Review 2012; 14 (1)


Lipid levels as predictors of silent myocardial ischemia in a Type 2 diabetic population in Havana

Peña Y, Fernández-Britto JE, Bacallao J, Batista JF, de León ML

Idioma: Ingles.
Referencias bibliográficas: 34
Paginas: 18-24
Archivo PDF: 175.02 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Evans JM, Barnett KN, McMurdo ME, Morris AD. Reporting of diabetes on death certifi cates of 1872 people with type 2 diabetes in Tayside, Scotland. Eur J Public Health. 2008 Apr;18(2):201–3.

  2. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study. Diabetes Care. 2004 Aug;27(8):1954–61.

  3. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF. Prevalence and prognostic signifi cance of daily-life silent myocardial ischemia in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2005 Jul;26(14):1402–9.

  4. Zeman M, Zák A. [Pathogenesis and signifi - cance of diabetic dyslipidemia]. Cas Lek Cesk. 2004;143(5):302–6. Czech.

  5. Peña Y, Fernández-Britto JE, Coca MA, Batista JF, Rochela LM. Niveles de lípidos en sangre y SPECT de perfusión miocárdica en pacientes diabéticos tipo 2 asintomáticos [Internet]. Alasbimn Journal. 2006 Jul [cited 2011 Jul];8(33). Available from: http://www 2.alasbimnjournal.cl/alasbimn/CDA/imprime/ 0,1208,PRT%253D17528,00.html. Spanish.

  6. Yarnell JW, Patterson CC, Sweetnam PM, Thomas HF, Bainton D, Elwood PC, et al. Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Tenyear follow-up of Caerphilly and Speedwell Cohorts. Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1340–5.

  7. Nieto R, Martín A, Pereztol O. Estudios gated- SPECT en cardiología nuclear. Aspectos técnicos. In: Castro-Beiras JM, editor. Cardiología nuclear y otras técnicas no invasivas de imagen en cardiología. Madrid: Meditécnica; 2005. p. 115–21. Spanish.

  8. Casáns-Tormo I, Jurado-López JA. Diagnóstico de la enfermedad coronaria mediante gated- SPECT de perfusión miocárdica. Rev Esp Cardiol. 2008;8(Suppl B):S15–24. Spanish.

  9. Rojo JM. Árboles de clasifi cación y regresión [Internet]. Madrid: Consejo Superior de Investigaciones Científi cas; 2006 May [cited 2011 Jul]. 65 p. Available from: http://humanidad es.cchs.csic.es/cshs/web_UAE/tutoriales/PDF/ AnswerTree.pdf. Spanish.

  10. Anuario Estadístico de salud 2009. Havana: Ministry of Public Health (CU); 2009 [cited 2011 Jul]. Available from: http://bvs.sld.cu/cgi-bin/wxis/ anuario/ ?IsisScript=anuario/iah.xis&tag5003=a nuario&tag5021=e&tag6000=B&tag5013=GUES T&tag5022=2009. Spanish.

  11. O’Donnell CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol. 2008 Mar;61(3):299–310. Spanish.

  12. American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care. 2009 Jan;32 Suppl 1:S13–61.

  13. Committee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology, American Heart Association; Cardiovascular Imaging Committee, American College of Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine. Standardization of cardiac tomographic imaging. Circulation. 1992;86:338–9.

  14. Faber TL, Cooke CD, Folks RD, Vansant JP, Nichols KJ, De Puey EG, et al. Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. J Nucl Med. 1999;40:650–9.

  15. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines). A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) Endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001 Jun 19;103(24):3019–41.

  16. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002 Jan;25 Supp1 1:S33–49.

  17. Pasternak RC. Report of the Adult Treatment Panel III: The 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin. 2003 Aug;21(3):393–8.

  18. Koehli M, Monbaron D, Prior JO, Calcagni ML, Fivaz-Arbane M, Stauffer JC, et al. SPECT myocardial perfusion imaging: long-term prognostic value in diabetic patients with and without coronary artery disease. Nuklearmedizin. 2006;45(2):74–81.

  19. Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med. 2004 May;45(5):912–21.

  20. Peña Y, Coca MA, Batista JF, Fernández-Britto JE, Quesada R, Peña A. Utilidad de la tomografía computarizada de emisión de fotón único sincronizada con el electrocardiograma para la detección de isquemia miocárdica silente en diabéticos tipo 2. Rev Méd Chile. 2009;137:1023–30. Spanish.

  21. Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M. Reversible regional wall motion abnormalities on exercise technetium- 99m–gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am College of Cardiology. 2002;39:991–8.

  22. Candell-Riera J, De León G, Jurado-López JA, Diego-Domínguez M, Albert-Bertrand FX, Coma- Canellae I. Evidencias clínicas y recomendaciones del gated-SPECT de perfusión miocárdica. Rev Esp Cardiol. 2008;8 Suppl:58B–64. Spanish.

  23. Peña QY, Fernández-Britto JE, Bacallao J, Batista JF, Coca MA, Toirac N, et al. Diagnóstico de isquemia miocárdica silente en diabéticos tipo 2 mediante electrocardiograma, ergometría y Gated-SPECT [Internet]. Rev Cubana Invest Bioméd. 2008 Jul–Dec [cited 2011 May];27(3–4). Available from: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S0 864-03002008000300004&lng=es&nrm=iso&tln g=es. Spanish.

  24. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health. 2007 Jan;61(1):40–7.

  25. Skyler JS, Bergenstal R, Bonow RO, Buse J, Beedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA diabetes trials. A position statement of the American Diabetes Association and a scientifi c statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009 Jan;32(1):187–92.

  26. Salama I, Sánchez GA. Factores de riesgo y complicaciones crónicas en el diagnóstico reciente de la Diabetes tipo 2. Rev Cubana Endocrinol. 2001;12(2):76–81. Spanish.

  27. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P. Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol. 2002 Nov 22;1:5.

  28. El Harchaoui K, Arsenault BJ, Franssen R, Després JP, Hovingh GK, Stroes ES, et al. Highdensity lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009 Jan 20;150(2):84–93.

  29. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003 Jan;26 Suppl 1:S83–6.

  30. Cholesterol Treatment Trialists’ (CTT) Collaborators; Kearney PM, Blackwell L, Collins R, Keech A, Simes J, et al. Effi cacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008 Jan 12;371(9607):117–25.

  31. Suka M, Yoshida K, Yamauchi K. Impact of Body Mass Index on Cholesterol Levels of Japanese Adults. Intl J Clin Pract. 2006;60(7):770–82.

  32. Bacallao Gallestey J, Parapar de la Riestra JM, Roque M, Bacallao Guerra J. Árboles de regresión y otras opciones metodológicas aplicadas a la predicción del rendimiento académico. Educ Med Sup. 2004;18(3). Spanish.

  33. Cha SH, Tappert C. A genetic algorithm for constructing compact binary decision trees. J Pattern Recognition Res. 2009;4(1):1–13.

  34. Metsvaht T, Pisarev H, Ilmoja ML, Parm U, Maipuu L, Merila M, et al. Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identifi ed by classifi cation and regression tree analysis. BMC Pediatr. 2009 Nov 24;9:72.




2020     |     www.medigraphic.com